DE69132513T2 - Vorrichtung und verfahren zur festphase-präzipitationsbestimmung von hdl-cholesterin - Google Patents

Vorrichtung und verfahren zur festphase-präzipitationsbestimmung von hdl-cholesterin

Info

Publication number
DE69132513T2
DE69132513T2 DE69132513T DE69132513T DE69132513T2 DE 69132513 T2 DE69132513 T2 DE 69132513T2 DE 69132513 T DE69132513 T DE 69132513T DE 69132513 T DE69132513 T DE 69132513T DE 69132513 T2 DE69132513 T2 DE 69132513T2
Authority
DE
Germany
Prior art keywords
fluid sample
hdl
matrix
vldl
ldl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132513T
Other languages
English (en)
Other versions
DE69132513D1 (de
Inventor
M Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cholestech Corp
Original Assignee
Cholestech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/554,147 external-priority patent/US5213965A/en
Application filed by Cholestech Corp filed Critical Cholestech Corp
Application granted granted Critical
Publication of DE69132513D1 publication Critical patent/DE69132513D1/de
Publication of DE69132513T2 publication Critical patent/DE69132513T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D39/00—Filtering material for liquid or gaseous fluids
    • B01D39/14—Other self-supporting filtering material ; Other filtering material
    • B01D39/20—Other self-supporting filtering material ; Other filtering material of inorganic material, e.g. asbestos paper, metallic filtering material of non-woven wires
    • B01D39/2003—Glass or glassy material
    • B01D39/2017—Glass or glassy material the material being filamentary or fibrous
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525—Multi-layer analytical elements
    • G01N33/526—Multi-layer analytical elements the element being adapted for a specific analyte
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0414—Surface modifiers, e.g. comprising ion exchange groups
    • B01D2239/0421—Rendering the filter material hydrophilic
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
    • B01D2239/04—Additives and treatments of the filtering material
    • B01D2239/0471—Surface coating material
    • B01D2239/0492—Surface coating material on fibres
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00—Chromogens for determinations of oxidoreductase enzymes
    • C12Q2326/90—Developer
    • C12Q2326/96—4-Amino-antipyrine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
DE69132513T 1990-07-16 1991-07-15 Vorrichtung und verfahren zur festphase-präzipitationsbestimmung von hdl-cholesterin Expired - Fee Related DE69132513T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/554,147 US5213965A (en) 1990-07-16 1990-07-16 Solid-phase precipitation assay device
US07/729,447 US5213964A (en) 1990-07-16 1991-07-12 High-density lipoprotein solid-base precipitation assay method
PCT/US1991/005004 WO1992001498A2 (en) 1990-07-16 1991-07-15 Solid-phase precipitation assay device and method

Publications (2)

Publication Number Publication Date
DE69132513D1 DE69132513D1 (de) 2001-02-22
DE69132513T2 true DE69132513T2 (de) 2001-08-23

Family

ID=27070513

Family Applications (2)

Application Number Title Priority Date Filing Date
DE9117297U Expired - Lifetime DE9117297U1 (de) 1990-07-16 1991-07-15 Vorrichtung zur Festphasen-Präzipdation
DE69132513T Expired - Fee Related DE69132513T2 (de) 1990-07-16 1991-07-15 Vorrichtung und verfahren zur festphase-präzipitationsbestimmung von hdl-cholesterin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE9117297U Expired - Lifetime DE9117297U1 (de) 1990-07-16 1991-07-15 Vorrichtung zur Festphasen-Präzipdation

Country Status (9)

Country Link
US (3) US5213964A (de)
EP (2) EP1028319A3 (de)
JP (1) JP2981774B2 (de)
AT (1) ATE198796T1 (de)
AU (1) AU656733B2 (de)
CA (1) CA2087255C (de)
DE (2) DE9117297U1 (de)
ES (1) ES2155057T3 (de)
WO (1) WO1992001498A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204606C1 (de) * 2002-01-18 2003-10-16 Cholestech Corp Vorrichtung und Verfahren für Lipoproteine hoher Dichte

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
USRE39915E1 (en) 1989-09-01 2007-11-06 Roche Diagnostics Gmbh Method for the determination of HDL cholesterol by means of a rapid diagnostic agent with an integrated fractionating step
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
US5286626A (en) * 1991-12-13 1994-02-15 Actimed Laboratories, Inc. Process and apparatus for direct determination of low density lipoprotein
JP2653755B2 (ja) * 1994-03-08 1997-09-17 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
JP2600065B2 (ja) * 1994-03-08 1997-04-16 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの定量法
JP3256241B2 (ja) * 1995-03-16 2002-02-12 協和メデックス株式会社 低密度リポ蛋白中のコレステロールの定量法
US5981294A (en) * 1995-11-29 1999-11-09 Metrika, Inc. Device for blood separation in a diagnostic device
US5968839A (en) * 1996-05-13 1999-10-19 Metrika, Inc. Method and device producing a predetermined distribution of detectable change in assays
US5945345A (en) * 1996-08-27 1999-08-31 Metrika, Inc. Device for preventing assay interference using silver or lead to remove the interferant
US20020182749A1 (en) * 1999-05-11 2002-12-05 Aclara Biosciences, Inc. Sample evaporative control
DE19962577A1 (de) * 1999-12-23 2001-07-12 Tittgen Biotechnologie Dr Chromatographiematerial und Verfahren unter Verwendung desselben
AU2002241602A1 (en) * 2000-11-16 2002-06-11 Burstein Technologies, Inc. Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
US20030143637A1 (en) * 2001-08-31 2003-07-31 Selvan Gowri Pyapali Capture layer assemblies for cellular assays including related optical analysis discs and methods
AU2002335715A1 (en) * 2001-09-07 2003-03-24 Burstein Technologies, Inc. Optical bio-disc systems for nuclear morphology based identification
EP1448992A4 (de) * 2001-11-20 2005-11-02 Burstein Technologies Inc Optische bio-disks und fluidische kreisläufe zur analyse von zellen und damit verbundene verfahren
WO2003056163A1 (en) * 2001-12-21 2003-07-10 Polymer Technology Systems, Inc. Test strip and method for determining hdl cholesterol concentration from whole blood of plasma
AU2002364609B2 (en) * 2001-12-28 2008-04-03 Polymer Technology Systems, Inc. Test strip for determining concentration of multiple analytes in a single fluid sample
DE60207196T2 (de) * 2002-04-09 2006-07-20 Cholestech Corp., Hayward Verfahren und Vorrichtung zur Quantifizierung von Lipoprotein-Cholesterol hoher Dichte
US7597936B2 (en) * 2002-11-26 2009-10-06 University Of Utah Research Foundation Method of producing a pigmented composite microporous material
EP1576351A4 (de) * 2002-11-26 2010-06-23 Univ Utah Res Found Mikroporöse materialien; verfahren undartikel zur lokalisierung und quantifizierung von analyten
TWI333545B (en) * 2003-04-02 2010-11-21 Cholestech Corp Adhered membranes retaining porosity and biological activity
US20050074828A1 (en) * 2003-07-16 2005-04-07 Dimagno Theodore John Uae of lipase for high-density lipoprotein cholesterol detection
ES2303882T3 (es) * 2003-11-04 2008-09-01 Cholestech Corporation Membranas y laminados que contienen reactivos y sus procedimientos de preparacion.
US7772007B2 (en) 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
US7749775B2 (en) * 2006-10-03 2010-07-06 Jonathan Scott Maher Immunoassay test device and method of use
US7492312B2 (en) * 2006-11-14 2009-02-17 Fam Adly T Multiplicative mismatched filters for optimum range sidelobe suppression in barker code reception
ATE483165T1 (de) * 2007-01-09 2010-10-15 Cholestech Corp Vorrichtung und verfahren zur messung des ldl- assoziierten cholesterols
WO2009037784A1 (ja) * 2007-09-21 2009-03-26 Tya K. K. 体液成分の分析器具
PL2209814T3 (pl) 2007-11-13 2017-08-31 Bio-Technology General (Israel) Ltd. Proces sterylizacji przez filtrację z rozcieńczaniem dla lepkosprężystych biopolimerów
JP5313537B2 (ja) * 2008-04-10 2013-10-09 富士フイルム株式会社 高密度リポ蛋白コレステロール測定用乾式分析素子
US8460539B2 (en) * 2008-06-13 2013-06-11 Polymer Technology Systems, Inc. Hybrid strip
US9395373B2 (en) 2008-06-13 2016-07-19 Polymer Technology Systems, Inc. Hybrid strip
US9632080B2 (en) 2009-01-23 2017-04-25 Polymer Technology Systems, Inc. Diagnostic multi-layer dry phase test strip with integrated biosensors (“electrostrip”)
US9562256B2 (en) * 2010-10-23 2017-02-07 Pop Test LLC Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
WO2019175962A1 (ja) * 2018-03-13 2019-09-19 デンカ生研株式会社 循環器疾患等のリスクの判断を補助する方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
CA1095819A (en) * 1977-01-14 1981-02-17 Eastman Kodak Company Element for analysis of liquids
CH625399A5 (de) * 1978-01-20 1981-09-30 Nestle Sa
US4188188A (en) * 1978-09-27 1980-02-12 Bio-Rad Laboratories, Inc. High density lipoprotein cholesterol assay
US4215993A (en) * 1978-12-04 1980-08-05 Data Medical Associates, Inc. Precipitating reagent and method for isolation and determination of high density lipoproteins in human serum
JPH0142041Y2 (de) * 1978-12-11 1989-12-11
EP0111762B1 (de) * 1980-06-20 1987-11-19 Unilever Plc Verfahren und Gerät zur Durchführung spezifischer Bindungsbestimmungen
DE3029579C2 (de) * 1980-08-05 1985-12-12 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Mittel zur Abtrennung von Plasma oder Serum aus Vollblut
DE3208253A1 (de) * 1982-03-08 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur spezifischen bestimmung des cholesterins der ldl-fraktion im serum
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US4615946A (en) * 1985-03-29 1986-10-07 Ppg Industries, Inc. Chemically treated glass fibers for reinforcing polymeric matrices
JPS6211167A (ja) * 1985-07-09 1987-01-20 Fuji Photo Film Co Ltd コレステロ−ル分析用多層分析要素
US4711820A (en) * 1986-06-17 1987-12-08 Petrarch Systems Inc. Method of siliconization of surfaces with lower alkyl silanes
US4753776A (en) * 1986-10-29 1988-06-28 Biotrack, Inc. Blood separation device comprising a filter and a capillary flow pathway exiting the filter
US4987085A (en) * 1987-06-22 1991-01-22 Chemtrak Inc. Blood filtering metering device
GB8728310D0 (en) * 1987-12-03 1988-01-06 St Georges Hosp Medical School Method of estimation of systemic cholesterol concentrations from capillary blood samples
DE3826055A1 (de) * 1988-07-30 1990-02-01 Boehringer Mannheim Gmbh Mit reagenz abloesbar impraegnierte traegermatrix
US5082626A (en) * 1988-08-08 1992-01-21 Boehringer Mannheim Gmbh Wedge shaped test strip system useful in analyzing test samples, such as whole blood
JPH02210265A (ja) * 1989-02-10 1990-08-21 Konica Corp 分析素子
US5114350A (en) * 1989-03-08 1992-05-19 Cholestech Corporation Controlled-volume assay apparatus
CA2019865A1 (en) * 1989-07-12 1991-01-12 Yatin B. Thakore Device and method for separation of fluid components for component testing
DE3929032C2 (de) * 1989-09-01 1998-09-03 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von HDL-Cholesterin mittels eines Schnelldiagnostikums mit integriertem Fraktionierschritt
US5213964A (en) * 1990-07-16 1993-05-25 Cholestech Corporation High-density lipoprotein solid-base precipitation assay method
US5213965A (en) * 1990-07-16 1993-05-25 Cholestech Corporation Solid-phase precipitation assay device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204606C1 (de) * 2002-01-18 2003-10-16 Cholestech Corp Vorrichtung und Verfahren für Lipoproteine hoher Dichte

Also Published As

Publication number Publication date
CA2087255C (en) 1999-08-31
JPH06502911A (ja) 1994-03-31
JP2981774B2 (ja) 1999-11-22
WO1992001498A3 (en) 1992-03-05
US5451370A (en) 1995-09-19
US5213964A (en) 1993-05-25
ATE198796T1 (de) 2001-02-15
DE69132513D1 (de) 2001-02-22
DE9117297U1 (de) 2000-08-03
AU656733B2 (en) 1995-02-16
CA2087255A1 (en) 1992-01-17
EP1028319A3 (de) 2004-01-21
US5316916A (en) 1994-05-31
EP0539495A1 (de) 1993-05-05
AU8298691A (en) 1992-02-18
EP1028319A2 (de) 2000-08-16
ES2155057T3 (es) 2001-05-01
EP0539495B1 (de) 2001-01-17
WO1992001498A2 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
ATE198796T1 (de) Vorrichtung und verfahren zur festphase- präzipitationsbestimmung von hdl-cholesterin
US5053344A (en) Magnetic field separation and analysis system
EP0556202B1 (de) Verbessertes bestimmungsverfahren für liganden
ATE203826T1 (de) Verfahren und vorrichtung zur bestimmung eines analyten, insbesondere eines bakteriums, auf magnetischem wege
EP0290921A3 (en) Test-piece for the analysis of a liquid sample and method for its preparation
FR2535058B1 (fr) Dispositif pour la detection et la quantification d'agglutinats
DE3871768T2 (de) Kuevette und apparat zur ausfuehrung biologischer nachweise.
FI903515A0 (fi) Testimenetelmä ja reagenssikitti sitä varten
DE69321480D1 (de) Verfahren und detektor für trennungsprozesse
DE69011198D1 (de) Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes.
ATE129347T1 (de) Biologisch aktive reagenzien aus carboxylgruppenhaltigen polymerisaten, analytisches element und verfahren zur verwendung.
ATE48157T1 (de) Ein zwitterion als bindungsmittel enthaltende zusammensetzung und testvorrichtung zum nachweis von leukozyten.
DE69209935T2 (de) Verfahren und magnetische Vorrichtung zur immunologischen Analyse von Festphasen
ATE147166T1 (de) Verfahren und vorrichtung zur bestimmung eines analyten in einer probe
DE69218981T2 (de) Verfahren zum Nachweis freier IGF-I, IGF-II, und GH Spiegel in Körperflüssigkeiten
ATE26187T1 (de) Vorrichtung zum homogenen spezifischen bindungsassay, verfahren zu deren herstellung und analytisches verfahren zur anwendung der vorrichtung.
DE3672388D1 (de) Einrichtung und verfahren fuer zytologische und histologische untersuchungen von objekttraegerpraeparaten.
ATE183312T1 (de) Verfahren zur reinigung und detektion von lipoprotein (a) und assoziiertem cholesterol
ATE153764T1 (de) Vorrichtung und verfahren zur durchführung biologischer assays, die ein partikelsiebsystem enthalten
EP0617790B1 (de) Diagnostisches testsystem
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
Saleemuddin Reducing sample loss during the filtration of protein precipitates
ATA253989A (de) Vorrichtung zur anreicherung von analyten aus flüssigen proben

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee